# Zoetis

Cytopoint, Apoquel, Vaccines — Recombinant mAbs, viral vectors.

Source: https://cn.bioecon.ru/companies/zoetis/
Updated: 2026-06-25

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 营收 | $95亿（2025年） | https://s203.q4cdn.com/620628704/files/doc_presentations/2026/04/IR-Zoetis-Corporate-Overview-April-2026.pdf, https://s203.q4cdn.com/620628704/files/doc_presentations/2026/06/updated/IR-Zoetis-Corporate-Overview.pdf, https://www.zoetis.com/our-company/our-story/zoetis-at-a-glance |
| 员工人数 | 全球约14,500名员工 | https://s203.q4cdn.com/620628704/files/doc_presentations/2026/04/IR-Zoetis-Corporate-Overview-April-2026.pdf, https://s203.q4cdn.com/620628704/files/doc_presentations/2026/06/updated/IR-Zoetis-Corporate-Overview.pdf, https://www.sec.gov/Archives/edgar/data/1555280/000130817926000228/zts015237-ars.pdf, https://www.zoetis.com/our-company/our-story/zoetis-at-a-glance |
| 生产基地 | 全球21至23个生产基地，包括美国（Kalamazoo、Lincoln、Durham、Buellton、Union City、Atlanta）、爱尔兰、比利时、西班牙、意大利、巴西、澳大利亚、新西兰和中国 | https://s203.q4cdn.com/620628704/files/doc_presentations/2026/04/IR-Zoetis-Corporate-Overview-April-2026.pdf, https://s203.q4cdn.com/620628704/files/doc_presentations/2026/06/updated/IR-Zoetis-Corporate-Overview.pdf, https://www.zoetis.com/products-and-science/manufacturing-supply |
| 产能 | Zoetis已扩大爱尔兰Tullamore基地的单克隆抗体（mAbs）产能，并投资$5.9亿在美国佐治亚州新建单抗与疫苗设施 | https://news.zoetis.com/press-releases/press-release-details/2021/Zoetis-to-Expand-its-Manufacturing-Capability-in-Tullamore-Ireland/default.aspx |
| 监管批准 | Apoquel、Cytopoint及多种重组载体疫苗（如Poulvac Procerta系列）等主要产品已获FDA（美国）、USDA（美国）以及EMA等国际监管机构针对不同适应症与地区市场的批准 | https://investor.zoetis.com/news/news-details/2026/Zoetis-Reports-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx, https://www.keypedia.com/records/eir/zoetis-belgium-sa/2c5d1500-a520-4966-b1e8-47a824797482, https://www.sec.gov/Archives/edgar/data/1555280/000130817926000228/zts015237-ars.pdf, https://www.sec.gov/Archives/edgar/data/1555280/000155528023000074/zts-20221231.htm, https://www.vmd.defra.gov.uk/register/good-manufacturing-practice/cerficate/VMDGMP/M240/2026, https://www.zoetis.com/products-and-science/manufacturing-supply |
| 认证 | Zoetis各基地维持全球监管合规，包括就药品与生物制品生产取得VMD（英国）与FDA（美国）等机构的良好生产规范（GMP）认证 | https://www.vmd.defra.gov.uk/register/good-manufacturing-practice/cerficate/VMDGMP/M240/2026, https://www.zoetis.com/products-and-science/manufacturing-supply |

独立来源: keypedia.com, s203.q4cdn.com, sec.gov, vmd.defra.gov.uk

## 技术

- [One Health — 人兽共患病与耐药性监测服务](https://cn.bioecon.ru/technology/one-health-zoonosis-amr-monitoring/)
- [兽医基因组学与伴侣动物诊断](https://cn.bioecon.ru/technology/veterinary-genomics-companion-animal-diagnostics/)
- [兽医生物技术与 mRNA 兽药](https://cn.bioecon.ru/technology/veterinary-biotech-mrna-drugs/)